Basics Keros Therapeutics, Inc. IPO Date: April 8, 2020 Sector: Healthcare Industry: Biotech Market Cap: $462.78M Activated in VL: True Average Daily Range Avg Daily Range: $1.16 | 2.67% Avg Daily Range (30 D): $0.29 | 1.87% Avg Daily Range (90 D): $0.24 | 1.64% Institutional Daily Volume Avg Daily Volume: .27M Avg Daily Volume (30 D): .6M Avg Daily Volume (90 D): .44M Trade Size Avg Trade Size (Sh.): 60 Avg Trade Size (Sh.) (30 D): 79 Avg Trade Size (Sh.) (90 D): 68 Institutional Trades Total Inst.Trades: 1,980 Avg Inst. Trade: $1.87M Avg Inst. Trade (30 D): $1.53M Avg Inst. Trade (90 D): $1.38M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.91M Avg Closing Trade (30 D): $1.23M Avg Closing Trade (90 D): $1.14M Avg Closing Volume: 54.78K     News Sep 23, 2025 @ 5:00 PM TGF-β Inhibitors Clinical Trial Pipeline Accele... Source: Delveinsight May 27, 2025 @ 5:45 PM Leading Independent Proxy Advisory Firm Glass Lewi... Source: Keros Therapeutics, Inc. May 12, 2025 @ 5:00 PM Blood Cancer Treatment Market Sees Accelerated Gro... Source: Delveinsight Apr 11, 2025 @ 6:35 PM Deal Dispatch: Harley-Davidson To Wipe Out? Plus, ... Source: Anthony Noto Apr 10, 2025 @ 5:51 PM Keros Therapeutics Goes Up For Sale On Heels Of St... Source: Vandana Singh Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.76 $3.66 $-1.12 Diluted EPS $-.76 $3.62 $-1.12 Revenue $ 18.17M $ 211.19M $ 3.04M Gross Profit $ $ $ Net Income / Loss $ -30.7M $ 148.45M $ -46.03M Operating Income / Loss $ -39.82M $ 152.04M $ -53.25M Cost of Revenue $ $ $ Net Cash Flow $ -30.33M $ 160.61M $ 29.25M PE Ratio